Yayın:
Current Status of mCRC in East Europe and Middle East.

dc.contributor.authorTurhal, S.N.
dc.contributor.authorGökhan Uçar
dc.contributor.authorVasileia Vamvakopoulou
dc.contributor.authorS.N. Turhal
dc.contributor.authorBirol Yıldız
dc.contributor.authorMichalis V. Karamouzis
dc.contributor.authorSinan Yavuz
dc.contributor.authorNuri Karadurmuş
dc.contributor.authorNurullah Zengin
dc.contributor.authorHüseyin Abalı
dc.contributor.authorRavit Geva
dc.contributor.orcid0000-0003-0038-3569
dc.contributor.orcid0000-0002-7649-1075
dc.contributor.orcid0000-0001-8920-6467
dc.contributor.orcid0000-0003-1369-8201
dc.contributor.orcid0000-0002-1479-6439
dc.contributor.orcid0000-0003-3291-8062
dc.contributor.orcid0000-0002-5568-9904
dc.contributor.orcid0000-0001-5596-0920
dc.contributor.orcid0000-0002-5380-4948
dc.date.accessioned2025-11-13T22:58:17Z
dc.date.issued2018-02-01
dc.identifier.doihttps://doi.org/10.1200/jco.2018.36.4_suppl.853
dc.identifier.endpage853
dc.identifier.issn0732-183X
dc.identifier.issue4_suppl
dc.identifier.openalexW2908477198
dc.identifier.startpage853
dc.identifier.urihttps://hdl.handle.net/11421/15913
dc.identifier.urihttps://doi.org/10.1200/jco.2018.36.4_suppl.853
dc.identifier.volume36
dc.language.isoen
dc.relation.ispartofJournal of Clinical Oncology
dc.rightsrestrictedAccess
dc.subjectMedicine
dc.subjectMetastasectomy
dc.subjectInternal medicine
dc.subjectBevacizumab
dc.subjectIrinotecan
dc.subjectAflibercept
dc.subjectOxaliplatin
dc.subjectColorectal cancer
dc.subjectGastroenterology
dc.subjectOncology
dc.subjectChemotherapy
dc.subjectSurgery
dc.subjectCancer
dc.titleCurrent Status of mCRC in East Europe and Middle East.
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5103886208

Dosyalar

Koleksiyonlar